Proactive Investors - Run By Investors For Investors

Amphion Innovations trims its stake in Motif Bio

Life sciences and technology incubator Amphion Innovations recently rolled over £6.56mln of promissory notes due in December 2018 for a year.
US dollars
One-third of the proceeds from the sale will be retained for working capital

Amphion Innovations PLC (LON:AMP) has reduced its stake in partner company Motif Bio PLC (LON:MTFB, NASDAQ:MTFB) to 7.88%.

It sold 1.83mln shares in Motif, generating US$1440,000, two-thirds of which will go to effect partial repayment of the loan facility it took out in mid-2014.

READ: Motif Bio to manage cash aggressively after making loan repayment

Prior to the sale, Amphion’s stake in Motif Bio, which is developing iclaprim, a next-generation antibiotic, was 8.51%.


View full AMP profile View Profile

Amphion Innovations PLC Timeline

Related Articles

March 04 2019
The company’s main focus is on the use of field-programmable gate array (FPGA) technology, a programmable system that helps to reduce pressure on computer processors
Keywords Studio
January 28 2019
Keywords has a buy-and-build strategy and has been expanding rapidly since its first acquisition in 2014.
November 16 2018
The e-learning specialist upgraded its long-term goals to run-rate revenues of £200mln and run-rate underlying earnings of at least £55mln by 2021, an increase of around 100%

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use